Who should get first dibs on Pfizer’s COVID pill?
Opinion, Сolumns
January 4, 2022

Who should get first dibs on Pfizer’s COVID pill?

Scientists who’ve been reluctant to talk up any new COVID-19 treatment are suddenly using the expression “game changer” to describe the Pfizer antiviral pill Paxlovid. But the changed game will

bradford

The Bradford Era

Local & Social